| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 43 | 2023 | 613 | 10.160 |
Why?
|
| Early Detection of Cancer | 39 | 2023 | 501 | 8.510 |
Why?
|
| Hypertension | 31 | 2023 | 500 | 6.710 |
Why?
|
| Mass Screening | 29 | 2023 | 661 | 4.560 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 20 | 2023 | 51 | 4.510 |
Why?
|
| Occult Blood | 26 | 2020 | 153 | 4.390 |
Why?
|
| Telemedicine | 13 | 2022 | 182 | 2.870 |
Why?
|
| Postal Service | 15 | 2020 | 72 | 2.800 |
Why?
|
| Patient Compliance | 10 | 2017 | 298 | 2.750 |
Why?
|
| Antihypertensive Agents | 13 | 2022 | 161 | 2.590 |
Why?
|
| Feces | 10 | 2020 | 80 | 2.380 |
Why?
|
| Humans | 100 | 2023 | 17611 | 2.320 |
Why?
|
| Reminder Systems | 8 | 2020 | 80 | 2.270 |
Why?
|
| Colonoscopy | 16 | 2023 | 251 | 2.100 |
Why?
|
| Middle Aged | 57 | 2023 | 7911 | 2.060 |
Why?
|
| Blood Pressure | 14 | 2023 | 298 | 2.000 |
Why?
|
| Aged | 48 | 2023 | 6095 | 1.900 |
Why?
|
| Male | 57 | 2022 | 10008 | 1.820 |
Why?
|
| Electronic Health Records | 15 | 2020 | 681 | 1.820 |
Why?
|
| Female | 65 | 2023 | 12608 | 1.760 |
Why?
|
| Internet | 8 | 2014 | 231 | 1.680 |
Why?
|
| Research Design | 8 | 2020 | 374 | 1.610 |
Why?
|
| Patient-Centered Care | 5 | 2016 | 197 | 1.610 |
Why?
|
| Patient Acceptance of Health Care | 7 | 2020 | 382 | 1.560 |
Why?
|
| Medicaid | 6 | 2020 | 186 | 1.540 |
Why?
|
| Motivation | 4 | 2021 | 130 | 1.530 |
Why?
|
| Primary Health Care | 11 | 2022 | 766 | 1.470 |
Why?
|
| Pharmacists | 11 | 2022 | 48 | 1.400 |
Why?
|
| Patient Selection | 5 | 2016 | 190 | 1.330 |
Why?
|
| Blood Pressure Determination | 8 | 2023 | 54 | 1.280 |
Why?
|
| Washington | 12 | 2021 | 374 | 1.150 |
Why?
|
| Colonic Neoplasms | 3 | 2020 | 155 | 1.120 |
Why?
|
| Medicare | 7 | 2023 | 202 | 1.100 |
Why?
|
| Patient Care Team | 5 | 2014 | 113 | 1.050 |
Why?
|
| Reagent Kits, Diagnostic | 2 | 2015 | 10 | 0.960 |
Why?
|
| Pharmaceutical Services | 4 | 2013 | 34 | 0.930 |
Why?
|
| Follow-Up Studies | 12 | 2020 | 1210 | 0.890 |
Why?
|
| Cardiovascular Diseases | 5 | 2021 | 598 | 0.840 |
Why?
|
| Practice Guidelines as Topic | 5 | 2019 | 318 | 0.830 |
Why?
|
| Safety-net Providers | 4 | 2020 | 51 | 0.800 |
Why?
|
| Physicians, Primary Care | 1 | 2023 | 72 | 0.800 |
Why?
|
| United States | 20 | 2023 | 3956 | 0.740 |
Why?
|
| Telephone | 5 | 2019 | 161 | 0.660 |
Why?
|
| Time Factors | 8 | 2020 | 1086 | 0.650 |
Why?
|
| Healthcare Disparities | 5 | 2021 | 201 | 0.650 |
Why?
|
| Comparative Effectiveness Research | 3 | 2020 | 66 | 0.640 |
Why?
|
| Randomized Controlled Trials as Topic | 10 | 2022 | 322 | 0.640 |
Why?
|
| Pragmatic Clinical Trials as Topic | 5 | 2022 | 57 | 0.630 |
Why?
|
| Health Personnel | 2 | 2022 | 124 | 0.610 |
Why?
|
| Disease Management | 4 | 2020 | 135 | 0.600 |
Why?
|
| Adult | 21 | 2023 | 7598 | 0.570 |
Why?
|
| Cost-Benefit Analysis | 7 | 2023 | 250 | 0.570 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 375 | 0.570 |
Why?
|
| Case Management | 2 | 2015 | 32 | 0.560 |
Why?
|
| Patient Satisfaction | 3 | 2021 | 211 | 0.550 |
Why?
|
| Delivery of Health Care | 4 | 2022 | 415 | 0.550 |
Why?
|
| Patient Education as Topic | 4 | 2020 | 211 | 0.550 |
Why?
|
| Attitude of Health Personnel | 2 | 2017 | 212 | 0.550 |
Why?
|
| Evidence-Based Practice | 2 | 2013 | 46 | 0.540 |
Why?
|
| Motor Activity | 3 | 2015 | 212 | 0.540 |
Why?
|
| Community Health Centers | 2 | 2020 | 64 | 0.530 |
Why?
|
| Specimen Handling | 1 | 2016 | 20 | 0.530 |
Why?
|
| Weight Loss | 4 | 2022 | 303 | 0.520 |
Why?
|
| Hispanic Americans | 2 | 2014 | 404 | 0.500 |
Why?
|
| Patient Participation | 1 | 2016 | 133 | 0.500 |
Why?
|
| Program Development | 3 | 2020 | 69 | 0.490 |
Why?
|
| Lipids | 1 | 2015 | 77 | 0.490 |
Why?
|
| Smartphone | 1 | 2014 | 11 | 0.490 |
Why?
|
| Patient Navigation | 1 | 2014 | 14 | 0.480 |
Why?
|
| Mobile Applications | 1 | 2014 | 17 | 0.480 |
Why?
|
| Negotiating | 1 | 2014 | 4 | 0.470 |
Why?
|
| Surveys and Questionnaires | 7 | 2021 | 1309 | 0.460 |
Why?
|
| Health Care Reform | 1 | 2014 | 31 | 0.460 |
Why?
|
| Self Efficacy | 1 | 2014 | 68 | 0.460 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2014 | 20 | 0.460 |
Why?
|
| Chronic Disease | 2 | 2015 | 428 | 0.460 |
Why?
|
| Preventive Health Services | 2 | 2014 | 159 | 0.450 |
Why?
|
| Health Literacy | 1 | 2014 | 39 | 0.440 |
Why?
|
| Family Practice | 1 | 2013 | 44 | 0.440 |
Why?
|
| Health Services Accessibility | 3 | 2021 | 289 | 0.430 |
Why?
|
| Advisory Committees | 1 | 2014 | 110 | 0.430 |
Why?
|
| Qualitative Research | 6 | 2020 | 254 | 0.420 |
Why?
|
| Anxiety | 1 | 2013 | 150 | 0.410 |
Why?
|
| Population Surveillance | 1 | 2014 | 263 | 0.400 |
Why?
|
| Cholesterol | 1 | 2012 | 106 | 0.400 |
Why?
|
| Nurses | 1 | 2011 | 36 | 0.390 |
Why?
|
| Risk Factors | 8 | 2023 | 3325 | 0.380 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2023 | 119 | 0.380 |
Why?
|
| Treatment Outcome | 6 | 2015 | 1259 | 0.370 |
Why?
|
| Office Visits | 1 | 2011 | 80 | 0.370 |
Why?
|
| Papillomavirus Infections | 2 | 2023 | 133 | 0.370 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 169 | 0.360 |
Why?
|
| Patient Care | 2 | 2008 | 35 | 0.360 |
Why?
|
| Interviews as Topic | 5 | 2017 | 305 | 0.360 |
Why?
|
| Obesity | 3 | 2011 | 837 | 0.350 |
Why?
|
| Sigmoidoscopy | 4 | 2014 | 65 | 0.340 |
Why?
|
| Self Care | 3 | 2022 | 163 | 0.320 |
Why?
|
| Quality Improvement | 3 | 2022 | 189 | 0.310 |
Why?
|
| Remote Consultation | 1 | 2008 | 9 | 0.310 |
Why?
|
| Body Mass Index | 1 | 2012 | 958 | 0.290 |
Why?
|
| Public Health | 4 | 2020 | 80 | 0.290 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2007 | 85 | 0.280 |
Why?
|
| Age Factors | 4 | 2015 | 917 | 0.280 |
Why?
|
| Sex Factors | 3 | 2015 | 643 | 0.280 |
Why?
|
| Socioeconomic Factors | 3 | 2021 | 630 | 0.270 |
Why?
|
| Quality of Life | 2 | 2015 | 507 | 0.250 |
Why?
|
| Oregon | 3 | 2020 | 171 | 0.240 |
Why?
|
| Pilot Projects | 2 | 2016 | 218 | 0.240 |
Why?
|
| Longitudinal Studies | 3 | 2016 | 710 | 0.240 |
Why?
|
| Program Evaluation | 4 | 2020 | 223 | 0.230 |
Why?
|
| Mammography | 2 | 2016 | 169 | 0.230 |
Why?
|
| Patient Preference | 2 | 2014 | 48 | 0.220 |
Why?
|
| Health Promotion | 2 | 2016 | 280 | 0.220 |
Why?
|
| Medication Adherence | 2 | 2016 | 244 | 0.210 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2013 | 531 | 0.210 |
Why?
|
| Alphapapillomavirus | 1 | 2022 | 13 | 0.210 |
Why?
|
| Exercise | 1 | 2007 | 489 | 0.200 |
Why?
|
| Breast Neoplasms | 2 | 2016 | 949 | 0.200 |
Why?
|
| Single-Blind Method | 2 | 2014 | 44 | 0.200 |
Why?
|
| Pandemics | 2 | 2021 | 287 | 0.190 |
Why?
|
| Quality Indicators, Health Care | 1 | 2003 | 181 | 0.190 |
Why?
|
| Electronic Mail | 3 | 2013 | 51 | 0.190 |
Why?
|
| Health Maintenance Organizations | 1 | 2003 | 417 | 0.190 |
Why?
|
| Racism | 1 | 2021 | 19 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 129 | 0.180 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2017 | 26 | 0.180 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 37 | 0.180 |
Why?
|
| Cross Infection | 1 | 2020 | 27 | 0.180 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2021 | 53 | 0.180 |
Why?
|
| Preventive Medicine | 2 | 2013 | 24 | 0.180 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 86 | 0.180 |
Why?
|
| Comorbidity | 3 | 2021 | 594 | 0.180 |
Why?
|
| Prognosis | 3 | 2020 | 606 | 0.180 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 351 | 0.180 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 69 | 0.180 |
Why?
|
| Medical Informatics | 2 | 2017 | 38 | 0.170 |
Why?
|
| Life Style | 3 | 2017 | 332 | 0.170 |
Why?
|
| Aged, 80 and over | 6 | 2023 | 1900 | 0.170 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 49 | 0.170 |
Why?
|
| Financial Support | 1 | 2019 | 5 | 0.170 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 56 | 0.170 |
Why?
|
| Retrospective Studies | 4 | 2023 | 2447 | 0.170 |
Why?
|
| Sodium Chloride, Dietary | 2 | 2016 | 9 | 0.170 |
Why?
|
| Demography | 1 | 2019 | 101 | 0.160 |
Why?
|
| Health Care Costs | 1 | 2020 | 228 | 0.150 |
Why?
|
| Attitude to Health | 1 | 2019 | 164 | 0.150 |
Why?
|
| Infertility, Female | 2 | 1988 | 11 | 0.150 |
Why?
|
| Kidney Failure, Chronic | 1 | 2019 | 147 | 0.150 |
Why?
|
| Organizational Culture | 1 | 2017 | 18 | 0.150 |
Why?
|
| Awareness | 1 | 2017 | 17 | 0.150 |
Why?
|
| Culturally Competent Care | 1 | 2017 | 11 | 0.150 |
Why?
|
| Neoplasms | 1 | 2022 | 438 | 0.140 |
Why?
|
| Leadership | 1 | 2017 | 39 | 0.140 |
Why?
|
| Medically Uninsured | 2 | 2014 | 44 | 0.140 |
Why?
|
| Information Dissemination | 1 | 2017 | 51 | 0.140 |
Why?
|
| Risk Assessment | 3 | 2021 | 1097 | 0.140 |
Why?
|
| Classification | 1 | 2016 | 2 | 0.140 |
Why?
|
| Meta-Analysis as Topic | 2 | 2015 | 32 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2017 | 86 | 0.140 |
Why?
|
| Workflow | 1 | 2016 | 11 | 0.140 |
Why?
|
| Opioid-Related Disorders | 1 | 2019 | 167 | 0.130 |
Why?
|
| Focus Groups | 1 | 2016 | 147 | 0.130 |
Why?
|
| Aftercare | 1 | 2016 | 49 | 0.130 |
Why?
|
| Organizational Case Studies | 1 | 2015 | 21 | 0.130 |
Why?
|
| Hematologic Tests | 1 | 2015 | 3 | 0.130 |
Why?
|
| Communication | 2 | 2014 | 194 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 145 | 0.130 |
Why?
|
| Cluster Analysis | 1 | 2015 | 89 | 0.120 |
Why?
|
| Medically Underserved Area | 1 | 2014 | 12 | 0.120 |
Why?
|
| Inservice Training | 1 | 2014 | 14 | 0.120 |
Why?
|
| Comprehension | 1 | 2014 | 17 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 44 | 0.110 |
Why?
|
| Financing, Government | 1 | 2014 | 28 | 0.110 |
Why?
|
| Hypolipidemic Agents | 1 | 2014 | 40 | 0.110 |
Why?
|
| Accidental Falls | 1 | 2014 | 38 | 0.110 |
Why?
|
| Periodicals as Topic | 1 | 2013 | 14 | 0.110 |
Why?
|
| Language | 1 | 2014 | 51 | 0.110 |
Why?
|
| Logistic Models | 2 | 2014 | 926 | 0.110 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2014 | 42 | 0.110 |
Why?
|
| Utilization Review | 1 | 2013 | 53 | 0.110 |
Why?
|
| Insurance Coverage | 1 | 2014 | 106 | 0.110 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 171 | 0.110 |
Why?
|
| Costs and Cost Analysis | 1 | 2013 | 80 | 0.110 |
Why?
|
| Community Health Services | 1 | 2013 | 83 | 0.110 |
Why?
|
| Directive Counseling | 1 | 2012 | 25 | 0.100 |
Why?
|
| Papillomaviridae | 2 | 2023 | 52 | 0.100 |
Why?
|
| California | 2 | 2017 | 2284 | 0.100 |
Why?
|
| Health Services Research | 1 | 2013 | 231 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 2015 | 368 | 0.100 |
Why?
|
| Risk | 2 | 2011 | 516 | 0.100 |
Why?
|
| Unnecessary Procedures | 1 | 2012 | 24 | 0.100 |
Why?
|
| Treatment Refusal | 1 | 2012 | 33 | 0.100 |
Why?
|
| Practice Patterns, Nurses' | 1 | 2011 | 4 | 0.100 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2011 | 8 | 0.100 |
Why?
|
| Nurse's Role | 1 | 2011 | 7 | 0.100 |
Why?
|
| Ovulation | 2 | 1988 | 5 | 0.100 |
Why?
|
| Diet | 1 | 2014 | 365 | 0.100 |
Why?
|
| Models, Organizational | 1 | 2011 | 55 | 0.100 |
Why?
|
| Forecasting | 1 | 2011 | 75 | 0.100 |
Why?
|
| Regression Analysis | 1 | 2012 | 297 | 0.100 |
Why?
|
| Outcome and Process Assessment (Health Care) | 1 | 2011 | 102 | 0.100 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 187 | 0.090 |
Why?
|
| Poisson Distribution | 1 | 2011 | 88 | 0.090 |
Why?
|
| Nursing Care | 1 | 2010 | 4 | 0.090 |
Why?
|
| Nursing Staff, Hospital | 1 | 2010 | 11 | 0.090 |
Why?
|
| Incidence | 3 | 2021 | 1255 | 0.090 |
Why?
|
| Sample Size | 1 | 2010 | 29 | 0.090 |
Why?
|
| Quality Control | 1 | 2010 | 45 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 381 | 0.090 |
Why?
|
| Allied Health Personnel | 1 | 2010 | 11 | 0.090 |
Why?
|
| Linear Models | 1 | 2011 | 231 | 0.090 |
Why?
|
| Educational Status | 1 | 2011 | 200 | 0.090 |
Why?
|
| Social Class | 1 | 2011 | 120 | 0.090 |
Why?
|
| Northwestern United States | 2 | 2016 | 53 | 0.090 |
Why?
|
| Continental Population Groups | 1 | 2012 | 302 | 0.090 |
Why?
|
| Health Behavior | 1 | 2012 | 359 | 0.080 |
Why?
|
| Data Collection | 1 | 2010 | 256 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 454 | 0.080 |
Why?
|
| Registries | 1 | 2010 | 471 | 0.080 |
Why?
|
| Adolescent | 4 | 2020 | 3651 | 0.080 |
Why?
|
| African Americans | 1 | 2011 | 472 | 0.070 |
Why?
|
| Process Assessment (Health Care) | 1 | 2007 | 24 | 0.070 |
Why?
|
| Body Weight | 1 | 1988 | 219 | 0.070 |
Why?
|
| Risk Reduction Behavior | 1 | 2007 | 108 | 0.070 |
Why?
|
| Physical Exertion | 1 | 1986 | 22 | 0.070 |
Why?
|
| Group Practice, Prepaid | 1 | 2006 | 7 | 0.070 |
Why?
|
| Chlamydia trachomatis | 1 | 2006 | 8 | 0.070 |
Why?
|
| Women's Health Services | 1 | 2006 | 20 | 0.070 |
Why?
|
| Chlamydia Infections | 1 | 2006 | 25 | 0.070 |
Why?
|
| Quality of Health Care | 2 | 2014 | 326 | 0.070 |
Why?
|
| Primary Prevention | 1 | 2006 | 73 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2022 | 2570 | 0.060 |
Why?
|
| Breast Self-Examination | 1 | 2003 | 4 | 0.060 |
Why?
|
| Idaho | 2 | 2013 | 24 | 0.050 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2003 | 20 | 0.050 |
Why?
|
| Reimbursement, Incentive | 1 | 2022 | 27 | 0.050 |
Why?
|
| Suburban Health Services | 1 | 2002 | 1 | 0.050 |
Why?
|
| Physicians, Family | 1 | 2002 | 44 | 0.050 |
Why?
|
| Emotions | 1 | 2021 | 34 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2021 | 13 | 0.050 |
Why?
|
| Drug Monitoring | 1 | 2021 | 20 | 0.050 |
Why?
|
| Health Surveys | 1 | 2002 | 260 | 0.050 |
Why?
|
| Diabetes Mellitus | 2 | 2016 | 487 | 0.050 |
Why?
|
| Needs Assessment | 1 | 2021 | 66 | 0.050 |
Why?
|
| Italy | 1 | 2020 | 14 | 0.050 |
Why?
|
| Occupational Health | 1 | 2020 | 17 | 0.050 |
Why?
|
| Congresses as Topic | 1 | 2020 | 13 | 0.040 |
Why?
|
| Patient Safety | 1 | 2020 | 39 | 0.040 |
Why?
|
| Counseling | 1 | 2002 | 189 | 0.040 |
Why?
|
| Multimorbidity | 1 | 2020 | 14 | 0.040 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 36 | 0.040 |
Why?
|
| Immunochemistry | 1 | 2020 | 18 | 0.040 |
Why?
|
| Young Adult | 2 | 2020 | 2427 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2021 | 146 | 0.040 |
Why?
|
| Health Status | 1 | 2021 | 298 | 0.040 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2019 | 11 | 0.040 |
Why?
|
| Cause of Death | 1 | 2020 | 181 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 185 | 0.040 |
Why?
|
| Research Report | 1 | 2017 | 22 | 0.040 |
Why?
|
| Confidentiality | 1 | 2017 | 27 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 77 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 130 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1115 | 0.030 |
Why?
|
| Blood Pressure Monitors | 1 | 2016 | 2 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 1267 | 0.030 |
Why?
|
| Decision Making | 1 | 2017 | 183 | 0.030 |
Why?
|
| Hospitalization | 1 | 2021 | 797 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2015 | 42 | 0.030 |
Why?
|
| Text Messaging | 1 | 2015 | 29 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2016 | 179 | 0.030 |
Why?
|
| Consensus | 1 | 2014 | 41 | 0.030 |
Why?
|
| Video Recording | 1 | 2014 | 12 | 0.030 |
Why?
|
| Curriculum | 1 | 2014 | 35 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2013 | 10 | 0.030 |
Why?
|
| Editorial Policies | 1 | 2013 | 5 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 1322 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2013 | 24 | 0.030 |
Why?
|
| Emigrants and Immigrants | 1 | 2014 | 27 | 0.030 |
Why?
|
| Minority Groups | 1 | 2014 | 101 | 0.030 |
Why?
|
| Role Playing | 1 | 2012 | 1 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2012 | 230 | 0.020 |
Why?
|
| Oligomenorrhea | 1 | 1988 | 1 | 0.020 |
Why?
|
| Income | 1 | 1986 | 90 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2006 | 155 | 0.020 |
Why?
|